Aptinyx Inc. Common Stock
APTX
APTX was delisted on the 18th of May, 2023.
49 hedge funds and large institutions have $92.4M invested in Aptinyx Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 11 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
42% more call options, than puts
Call options by funds: $149K | Put options by funds: $105K
16% more capital invested
Capital invested by funds: $79.8M → $92.4M (+$12.6M)
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
2% less funds holding
Funds holding: 50 → 49 (-1)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$1.43M |
| 2 |
Millennium Management
New York
|
+$495K |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$403K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$212K |
| 5 |
Two Sigma Investments
New York
|
+$58.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$512K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$412K |
| 3 |
HF
HRT Financial
New York
|
-$162K |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$137K |
| 5 |
Two Sigma Advisers
New York
|
-$112K |
APTX Hedge Fund Activity: Q4 2021 in Review
49 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q4 2021, worth a combined $92.4M — up 16% from $79.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of APTX and 10 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 9 added.
The largest buyer was OrbiMed, adding an estimated $1.43M. The largest seller was Renaissance Technologies, cutting an estimated $512K.
- 49 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q4 2021, down from 50 in Q3 2021.
- Funds reported $92.4M of Aptinyx Inc. Common Stock stock for Q4 2021, up 16% quarter-over-quarter.
- 10 funds opened new Aptinyx Inc. Common Stock positions in Q4 2021 and 11 closed out, a net change of -1 holder.
- The largest Aptinyx Inc. Common Stock buyer in Q4 2021 was OrbiMed, an estimated $1.43M added.
- The largest Aptinyx Inc. Common Stock seller in Q4 2021 was Renaissance Technologies, an estimated $512K sold.
Based on aggregated 13F filings for Q4 2021.